Mandate

Vinge advises Adelis Equity Partners on the establishment of Adelis Equity Partners Fund IV

March 03, 2025 Private Funds

Vinge has advised Adelis Equity Partners on the establishment of Adelis’ fourth flagship fund: Adelis Equity Partners Fund IV.

The fund, which was significantly oversubscribed, held its final closing on 28 February 2025 after having raised commitments of EUR 1.6 billion from an investor base consisting of leading pension funds, foundations and fund-of-funds across Europe and North America, and from the Adelis team. The fund raise entails a more than 50% increase in commitments relative to the predecessor fund, Adelis Equity Partners Fund III. Since its commencement in 2013, Adelis invests in well-positioned companies in the Nordic and DACH regions and has to date made 45 platform investments and more than 260 add-on acquisitions.

Vinge’s team primarily consisted of Mattias Schömer, Nils Unckel, Martin Cronsioe, Ulf Nilsson, Mikaela Reinhammar, Anton Sjökvist, Emelie Svanberg, Tobias Onegård Karlsson, Viktoria Wnuk, Rebecka Margolin, Saga Meyer Viklund and Emelie Zingmark.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026